United Therapeutics Corporation shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in United Therapeutics Corporation
Tip: Access up to 7 years of quarterly data
All positions including United Therapeutics Corporation held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in United Therapeutics Corporation by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $9.7M | 23k | 419.21 |
| 2025-06-30 | $7.0M | 24k | 287.35 |
| 2025-03-31 | $7.6M | 25k | 308.27 |
| 2024-12-31 | $8.9M | 25k | 352.84 |
| 2024-09-30 | $8.2M | 23k | 358.35 |
| 2024-06-30 | $7.4M | 23k | 318.55 |
| 2023-12-31 | $5.8M | 26k | 219.89 |
| 2023-09-30 | $6.1M | 27k | 225.87 |
| 2023-06-30 | $6.2M | 28k | 220.75 |
| 2023-03-31 | $6.3M | 28k | 223.96 |
| 2022-12-31 | $8.0M | 29k | 278.09 |
| 2022-09-30 | $6.1M | 29k | 209.38 |
| 2022-06-30 | $6.9M | 29k | 235.64 |
| 2022-03-31 | $5.2M | 29k | 179.39 |
| 2021-12-31 | $4.7M | 22k | 216.07 |
| 2021-09-30 | $4.1M | 22k | 184.58 |
| 2021-06-30 | $4.0M | 22k | 179.41 |
| 2021-03-31 | $4.0M | 24k | 167.27 |
| 2020-12-31 | $3.7M | 24k | 151.79 |
| 2020-09-30 | $2.6M | 25k | 101.00 |
| 2020-06-30 | $3.2M | 26k | 121.02 |
| 2020-03-31 | $2.4M | 25k | 94.81 |
| 2019-12-31 | $2.2M | 25k | 88.10 |
| 2019-09-30 | $2.0M | 26k | 79.75 |
| 2019-06-30 | $2.0M | 26k | 78.06 |
| 2019-03-31 | $3.1M | 27k | 117.37 |
| 2018-12-31 | $2.9M | 27k | 108.90 |
| 2018-09-30 | $3.4M | 27k | 127.90 |
| 2018-06-30 | $3.1M | 27k | 113.17 |
| 2018-03-31 | $3.0M | 27k | 112.36 |
| 2017-12-31 | $4.0M | 27k | 147.95 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors
Top funds holding United Therapeutics Corporation
View all funds holding United Therapeutics Corporation